Cite
HARVARD Citation
Lissitchkov, T. et al. (2018). Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. Transfusion. 58 (2), pp. 413-422. [Online].